How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
The final day has come for World of Warcraft private server network Turtle WoW. Nearly eight years since it opened its doors to lost players looking for an alternative option, the fan-operated group ...
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
High schooler Evan Budz's award-winning invention can identify coral bleaching, invasive species, and microplastics without disturbing marine ecosystems. By Laura Kiniry Published May 12, 2026 9:01 AM ...
To celebrate World Turtle Day, we’d love to invite you to learn more about these ancient ocean dwellers. Discover fascinating facts and find out how you can take action to protect them. They are one ...
Turtle Beach and SteelSeries’ new models can do wireless hi-res audio, but it’s not the key reason you should upgrade. Turtle Beach and SteelSeries’ new models can do wireless hi-res audio, but it’s ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 10 Best Penny Stocks to Buy for Long Term. On May 14, 2026, Morgan Stanley raised the firm’s price target on Recursion Pharmaceuticals, Inc.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...